Ignite Creation Date:
2025-12-24 @ 4:43 PM
Ignite Modification Date:
2025-12-28 @ 7:38 AM
Study NCT ID:
NCT05735366
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-08-24
First Post:
2023-01-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1 Study of SAIL66 in Patients With CLDN6-positive Locally Advanced or Metastatic Solid Tumors
Sponsor:
Chugai Pharmaceutical
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-04-18
Start Date Type:
ACTUAL
Primary Completion Date:
2029-10-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-10-31
Completion Date Type:
ESTIMATED
First Submit Date:
2023-01-27
First Submit QC Date:
None
Study First Post Date:
2023-02-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-19
Last Update Post Date:
2025-08-24
Last Update Post Date Type:
ACTUAL